📰 Aktx News
Page 2 - Aktx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aktx. Real-time updates on events, politics, business and more.
October 26, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Akari Therapeutics stock opened at $3.60 on Monday. Akari Therapeutics has a twelve month low of $2.81 and a […]
October 19, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Up 1.2 % NASDAQ AKTX opened at $3.45 on Friday. Akari Therapeutics has a 12 month low of $2.81 and a 12 […]
October 19, 2023
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of NASDAQ AKTX opened at $3.45 on Friday. The business has a 50 day simple moving average of $3.67 and a […]
October 3, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of Akari Therapeutics stock opened at $3.88 on Friday. The company’s fifty day moving average price is $3.96 and […]
August 24, 2023
StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $3.61 on Friday. The firm has a fifty day moving average of $3.84 and a 200 […]
August 24, 2023
StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance AKTX opened at $3.61 on Friday. The stock has a market capitalization of $13.44 million, a P/E ratio of -0.52 […]
August 16, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 22.3 % Shares of Akari Therapeutics stock opened at $0.19 on Friday. The firm has a market cap of $14.03 […]
August 5, 2023
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 0.1 % Shares of NASDAQ:AKTX opened at $0.27 on Friday. The firm’s 50-day moving average is $0.18 and its […]
July 30, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 2.8 % AKTX stock opened at $0.22 on Thursday. Akari Therapeutics has a 1 year low of $0.14 and a 1 […]
July 23, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX opened at $0.17 on Wednesday. The company has a fifty day moving average price of $0.17 and a […]